Once-A-Day Hayfever & Allergy (Loratadine)

Loratadine is a selective peripheral H1‑receptor antagonist. By blocking H1 receptors on mast cells and sensory nerves, it prevents histamine‑mediated vasodilation, increased vascular permeability and nerve stimulation, thereby diminishing the typical signs of an allergic response.

The dosage is determined by the prescribing healthcare professional based on the patient’s age, condition severity and regulatory guidelines. Typically, adults and children above a certain age may receive a standard once‑daily dose, but the exact amount should follow the prescriber’s instruction.

Safety data are limited; loratadine should only be used during pregnancy or lactation if the potential benefit justifies the possible risk to the fetus or infant. Healthcare providers should evaluate individual circumstances before prescribing.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any required cold‑chain) and import documentation.

Loratadine is a second‑generation antihistamine with minimal sedation compared with first‑generation agents such as diphenhydramine. Its once‑daily dosing and favorable safety profile make it a preferred option for many patients, though efficacy is comparable across antihistamine classes for allergic symptom relief.

Store the tablets below 25 °C in their original container, protected from moisture and direct sunlight. Keep out of reach of children and do not use if the packaging is damaged. No refrigeration is required.

The tablet is taken orally with or without food, typically once a day as directed by a healthcare professional. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Although rare, serious adverse reactions can include anaphylaxis, Stevens‑Johnson syndrome, severe skin reactions, liver injury and cardiac arrhythmias. Patients should seek immediate medical attention if they experience swelling of the face or throat, rash, jaundice, or irregular heartbeat.

Loratadine is contraindicated in individuals with known hypersensitivity to loratadine or any excipients in the formulation. Caution is advised for patients with severe renal impairment, pregnant or breastfeeding women unless benefits outweigh risks, and those taking medications that may cause significant interactions.